Come up with a name for your new list and we'll add to it:
ImmuVen raised a round of funding on September 17, 2010. Investors include
Urbana-Champaign Angel Network.
ImmuVen develops drugs that can be used to treat infectious diseases and cancer. The company features life science technology, T cell receptors, a unique class of immune-targeting therapeutic and diag…